ResearchExpression of full-length p53 and its isoform Δp53 in breast carcinomas in relation to mutation status and clinical parameters1 Department of Genetics, Institute for Cancer Research, Rikshospitalet-Radiumhospitalet Medical Center, 0310 Oslo, Norway 2 Department of Medicine, Section of Oncology, Haukeland University Hospital, 5021 Bergen, Norway 3 Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie an der Universität Hamburg, Martinistr. 52, 20251 Hamburg, Germany 4 Medical Faculty, University of Oslo, Oslo, Norway
Molecular Cancer 2006, 5:47doi:10.1186/1476-4598-5-47
Additional filesAdditional File 1: mRNA and aa sequence of p53 and Δp53. p53 mRNA and its translated protein sequence. The untranslated precursor and untranslated region afterwards are illustrated with yellow highlights. Alternating exons are written in consecutive black and blue and translation codon triplets are marked with alternating white and light yellow. The removed alternative splice sequence of Δp53 is shown with light blue colour and the alternative splice cassettes are indicated with red. Sequence information is based on ENSEMBL notification [74]. Format: PDF Size: 64KB Download file This file can be viewed with: Adobe Acrobat Reader Additional File 2: p53 and Δp53 mutation specifications. This table lists the coded patient sample IDs, mutation classifications for p53 and Δp53 (including codon, nucleotides and aa changes), incidents of flagging primers and the numeric qRT-PCR expression levels. Format: PDF Size: 101KB Download file This file can be viewed with: Adobe Acrobat Reader Additional File 3: Relationship between Δp53 status and the standard clinical, pathological and biological factors. The data provided represent the relationship between Δp53 status and the standard clinical, pathological and biological factors. Format: PDF Size: 91KB Download file This file can be viewed with: Adobe Acrobat Reader |





on Google Scholar









author email
corresponding author email